Low Fluid Removal Rate in AKI Patients Linked to Higher Mortality: Study
Researchers have discovered that a low rate of fluid removal in patients with severe acute kidney injury (AKI) receiving continuous dialysis is related to a highly increased risk of dying within 90 days. In one of the largest retrospective studies at the University of Chicago, patients with less aggressive removal of fluids in the initial three days of continuous veno-venous hemodialysis (CVVHD) were found to have the highest mortality. This is in comparison to those with high or moderate fluid removal. These results stress the need for the maximization of fluid removal rates in order to enhance survival in critically ill patients with AKI. The study was published in the Journal of Critical Care by Samantha G. and colleagues.
Fluid overload is prevalent in patients with severe AKI and has been for a long time linked with adverse outcomes, such as longer-term dialysis dependence and death. However, little is known regarding how much fluid to remove, and how rapidly, to maximize outcomes during continuous dialysis. The study sought to investigate whether the rate of fluid removal via CVVHD contributed to mortality among ICU patients with AKI.
From April 1, 2016, to March 31, 2020, 1,242 adult ICU patients receiving CVVHD for AKI were included in this single-center retrospective cohort study. Scientists gathered data on daily fluid balance, pre-existing health status, and outcomes in patients to explore the relationship between fluid removal rate and survival.
The patients were stratified according to fluid removal rate in the first three days of CVVHD based on body-weight calculation. Low fluid removal rate was ≤1.01 mL/kg/h, and high fluid removal rate was >1.75 mL/kg/h. Variables at baseline like weight, pre-existing heart failure, and initial fluid overload were examined to ascertain their impact on patient outcomes. A multivariable adjusted hazard model was employed to determine the relationship between fluid removal rate and 90-day mortality.
Results
In the 1,242 patients analyzed:
Highest (74%) 90-day mortality occurred among patients who had a low fluid removal rate.
Low fluid removal, in an adjusted analysis for confounders, was independently related to increased 90-day mortality with an adjusted hazard ratio (AHR) of 2.74 (95% CI: 1.58–4.76).
Conversely, high fluid removal was unrelated to elevated mortality, and potentially provides a survival advantage (AHR: 0.50; 95% CI: 0.30–1.03), although without statistical significance.
Baseline group differences were for increased rates of congestive heart failure and variability in pre-CVVHD cumulative fluid balance and body weight.
This research concludes that low fluid removal rate during continuous dialysis in AKI patients is a significant and independent predictor of 90-day mortality. Although increased fluid removal rates were not adverse, they may be of benefit and need to be investigated further in clinical trials. These findings highlight the importance of close monitoring of fluid management strategies in the ICU environment, particularly in critically ill AKI patients on CVVHD.
Reference:
Gunning, S., Mire, M., Gulotta, G., & Koyner, J. (2025). Impact of fluid removal rate on patients receiving continuous renal replacement therapy for acute kidney injury. Journal of Critical Care, 89, 155161. https://doi.org/10.1016/j.jcrc.2025.155161
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.